Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
European Journal of Clinical Microbiology & Infectious Diseases
Published in: European Journal of Clinical Microbiology & Infectious Diseases 7/2006

01-07-2006 | Brief Report

Conservative management of a brain abscess in a patient with Staphylococcus lugdunensis endocarditis

Authors: S. Gianella, S. Ulrich, B. Huttner, R. Speich

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 7/2006

Login to get access

Excerpt

Brain abscess is defined as a focal, intracerebral infection that begins as a localized area of cerebritis and develops into a collection of pus surrounded by a well-vascularized capsule. Microorganisms can gain access to the brain through several mechanisms, most commonly by direct extension of an adjacent suppurative focus (i.e. otitis media, mastoiditis, or sinusitis) or by direct penetration via an open cerebrospinal fluid leak (e.g. after cranial fracture or neurosurgical complication). Another mechanism of brain abscess formation is hematogenous bacterial spread from a distant focus of infection, such as endocarditis. …
Literature
1.
Tunkel AR, Kaye D (1993) Neurologic complication of infective endocarditis. Neurol Clin 11:419–440PubMed
2.
Bhand AA (2004) Brain abscess—diagnosis and management. J Coll Physicians Surg Pak 14:407–410PubMed
3.
Rosenblum ML, Hoff JT, Norman D et al (1980) Nonoperative treatment of brain abscesses in selected high-risk patients. J Neurosurg 52:217–225PubMedCrossRef
4.
Fulgham JR, Wijdicks EFM, Wright AJ (1996) Cure of a solitary brainstem abscess with antibiotic therapy: case report. Neurology 46:1451–1454PubMed
5.
Chu VH, Cabell CH, Abrutyn E et al (2004) Native valve endocarditis due to coagulase-negative staphylococci: report of 99 episodes from the international collaboration on endocarditis merged database. Clin Infect Dis 39:1527PubMedCrossRef
6.
Freney J, Brun Y, Bes M et al (1988) Staphylococcus lugdunensis sp. nov. and Staphylococcus schleiferi sp. nov: two species from human clinical specimens. Int Syst J Bacteriol 38:168CrossRef
7.
Vandenesch F, Etienne J, Reverdy ME, Eykyn SJ (1993) Endocarditis due to Staphylococcus lugdunensis: report of 11 cases and review. Clin Infect Dis 17:871–876PubMed
8.
Herchline TE, Ayers LW (1991) Occurrence of Staphylococcus lugdunensis in consecutive clinical cultures and relationship of isolation to infection. J Clin Microbiol 29:419–421PubMed
9.
Anguera I, Del Rio A, Miró JM et al (2005) Staphylococcus lugdunensis infective endocarditis: description of 10 cases and analysis of native valve, prosthetic valve, and pacemaker lead endocarditis clinical profiles. Heart 91:e10PubMedCrossRef
10.
Seenivasan MH, Yu VL (2003) Staphylococcus lugdunensis endocarditis: the hidden peril of coagulase negative staphylococcus in blood cultures. Eur J Clin Microbiol Infect Dis 22:489–491PubMedCrossRef
11.
Carpenter JL (1994) Brain stem abscesses: cure with medical therapy, case report and review. Clin Infect Dis 18:219–226PubMed
12.
Sharma BS, Khosla VK, Kak VK et al (1995) Multiple pyogenic brain abscess. Acta Neurochir 133:36–43CrossRef
Metadata
Title
Conservative management of a brain abscess in a patient with Staphylococcus lugdunensis endocarditis
Authors
S. Gianella
S. Ulrich
B. Huttner
R. Speich
Publication date
01-07-2006
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 7/2006
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-006-0169-0

Other articles of this Issue 7/2006

European Journal of Clinical Microbiology & Infectious Diseases 7/2006 Go to the issue

Brief Report

Impact of age on clinical features and outcome of infective endocarditis

Article

Invasive Listeria monocytogenes infections in the Netherlands, 1995–2003

Article

Bacterial coinfections in children with viral wheezing

Article

Clonal variability of group B Streptococcus among different groups of carriers in southern Israel

Review

Attributable mortality of candidemia: a systematic review of matched cohort and case-control studies

Article

Increased incidence of Lyme borreliosis in southern Sweden following mild winters and during warm, humid summers
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits